MISSED OUT ON THE LATEST CLINICAL GUIDELINE ANNOUNCEMENTS?
No problem, we’ve got you covered! Here’s a list to all guidelines and FDA approvals that were published last month.
CLINICAL GUIDELINES
ACMG
ASCO
- Exercise, Diet, and Weight Management During Cancer Treatment
- Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- Management of Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases
AHA/ASA
AUA/ASTRO
- Clinically Localized Prostate Cancer: Introduction, Risk Assessment, Staging and Risk-Based Management
- Clinically Localized Prostate Cancer: Active Surveillance, Surgery and Follow-up
- Clinically Localized Prostate Cancer: Radiation and Future Directions
ASTRO
AUA
- Diagnosis and Management of Recurrent Ischemic Priapism, Priapism in Sickle Cell Patients and Non-Ischemic Priapism
- Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome
AACE
- Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
ABM
APTA
- Role of Physical Therapists in the Management of Individuals at Risk for or Diagnosed With Venous Thromboembolism
CNS
SCAI
SHEA
- Strategies to Prevent Ventilator-Associated Pneumonia, Ventilator-Associated Events, and Nonventilator Hospital-Acquired Pneumonia in Acute-Care Hospitals
SIS
- Antibiotic Use during Surgical Stabilization of Traumatic Rib or Sternal Fractures to Reduce Risk of Implant Infection
- Antibiotic Use in Patients Undergoing Cholecystectomy for Gallbladder Disease
SITC
SNMMI
EXCLUSIVE SOCIETY GUIDELINES AND MANY MORE!
Search, bookmark, add notes and create your personal clinical guideline library with your digital copy or one of our society and specialty subscription bundles.
FDA APPROVALS
MAY 2, 2022 CUVRIOR
Treatment of adult patients with stable Wilson’s disease who are de-coppered and tolerant to penicillamine
MAY 4, 2022 VOQUENZA
Treatment of Helicobacter pylori (H. pylori) infection in adults
MAY 13, 2022 RADICAVA ORS
Treatment of amyotrophic lateral sclerosis (ALS)
MAY 13, 2022 MOUNJARO
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes
MAY 19, 2022 IV TPOXX
Treatment of smallpox
MAY 24, 2022 VTAMA
Topical treatment of plaque psoriasis in adults
MAY 24, 2022 TYVASO DPI
Treatment of pulmonary arterial hypertension (PAH; WHO Group 1) and pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve exercise ability
MAY 25, 2022 DUPIXENT
To treat eosinophilic esophagitis patients 12 years and older
MAY 25, 2022 TIBSOVO
Treatment of patients with newly diagnosed IDH1-mutated acute myeloid leukemia (AML) in adults 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy
MAY 27, 2022 KYMRIAH
Treatment of adult patients with relapsed or refractory (r/r) follicular lymphoma (FL) after two or more lines of systemic therapy
MAY 27, 2022 OPDIVO
First-line treatment for adult patients with unresectable advanced or metastatic esophageal squamous cell carcinoma (ESCC) regardless of PD-L1 status
MAY 27, 2022 FYLNETRA
Multiple indications as biosimilar
MAY 31, 2022 EVRYSDI
Label extension to include infants under 2 months old with spinal muscular atrophy (SMA)
Copyright © 2022 Guideline Central, All rights reserved.